Inherited Blood Clotting Disorders

Inherited Blood Coagulation Disorders are conditions that run in families. They mean your blood doesn't clot properly, which can lead to bleeding or blood clots forming. This is because of changes in your genes that affect how your blood clots.

Condition

What people with Inherited Blood Clotting Disorders report

Every report comes from a Lived member, sent anonymously.

Have you tried Factor VIII for Inherited Blood Clotting Disorders?

NameHow it went

About Inherited Blood Clotting Disorders

What It Is

Inherited blood clotting disorders are conditions people are born with that change how their blood forms clots. Normal clotting depends on a balance. When a blood vessel is injured, platelets (small blood cells that plug the gap) and proteins called clotting factors build a clot, while other proteins keep clotting from going too far. An inherited change in one of the genes behind this system can tip the balance in either direction. This label covers two quite different groups. In inherited bleeding disorders, blood does not clot well enough, so bleeding lasts longer or starts more easily. Von Willebrand disease is the most common of these; hemophilia A and B are rarer but better known. In inherited thrombophilias, blood is more prone to forming clots where it should not, most often in the deep veins of the legs or in the lungs. Factor V Leiden and the prothrombin gene mutation, which make clotting proteins more active or more plentiful, are the most common; deficiencies of protein C, protein S or antithrombin, the body's natural brakes on clotting, are rarer and generally carry a higher clot risk. Severity varies widely. Some people have serious bleeding or clots early in life. Many with milder forms have no problems until an injury, surgery, childbirth or dental extraction, or learn about the condition only when a relative is diagnosed.

Causes & Risk Factors

These disorders come from gene variants passed from parents to children. They cannot be prevented, and nothing a person did caused them. The inheritance pattern depends on the condition. The hemophilia genes sit on the X chromosome, which is why hemophilia mostly affects males. When a mother carries the gene, each son has a 50% chance of having hemophilia and each daughter a 50% chance of being a carrier. Carriers can have bleeding problems of their own, sometimes noticed only after childbirth. Von Willebrand disease affects men and women about equally, although women often notice it more because of heavy periods. With thrombophilias, the gene variant raises risk but rarely acts alone. Between 3 and 8 percent of people of European ancestry carry factor V Leiden, yet only about 1 in 10 people with it ever develops an abnormal clot. To put the numbers in perspective, about 1 person in 1,000 in the general population develops an abnormal clot each year; one copy of factor V Leiden raises that to roughly 3 to 8 in 1,000. Clots tend to appear when another risk is added: surgery, injury, long periods without moving, pregnancy and the weeks after delivery, birth control or menopausal hormone therapy containing estrogen, smoking, obesity and older age. Inheriting two copies of a variant, or two different variants, raises the risk further. Bleeding and clotting problems can also be acquired later in life, from liver disease, blood thinners, autoimmune conditions or pregnancy, so a new problem in an adult is not automatically inherited.

How It's Diagnosed

Diagnosis starts with a detailed history: how easily you bruise, how long nosebleeds or cuts bleed, bleeding after dental work, surgery or childbirth, how heavy and long your periods are, any past clots or pregnancy losses, and who in the family has had bleeding problems or clots. Your clinician will also ask about medicines, because aspirin, blood thinners and some other drugs affect both symptoms and test results. For a suspected bleeding disorder, first-line blood tests include a complete blood count, which checks the platelet count, and two clotting-time tests: the prothrombin time (PT) and the activated partial thromboplastin time (aPTT). An abnormal result on one or the other points toward which group of clotting factors is involved. Specific factor tests then measure the level or activity of individual factors, such as factor VIII or IX for hemophilia, or the amount and function of von Willebrand factor. These screening tests can be normal in von Willebrand disease and mild hemophilia, so specific tests may still be needed when the bleeding history is suggestive. In hemophilia, the factor level sets the severity: the lower the level, the more often bleeding happens and the more likely it is to be serious. Genetic testing can confirm the exact variant and identify carriers, including before or during a pregnancy. For thrombophilia, blood tests look for the factor V Leiden and prothrombin variants and measure protein C, protein S and antithrombin. Testing is not routine for everyone. American Society of Hematology guidelines advise against screening the general population before starting combined birth control pills, and suggest testing mainly when a result would change a decision: whether to stop blood thinners after certain clots, how to protect someone during pregnancy, or whether a person from a family with a known high-risk deficiency should avoid estrogen. A hematologist, a doctor who specializes in blood disorders, usually guides this testing.

Treatment Options

Treatment depends on which disorder a person has and how severe it is. Some people with mild disorders need no regular treatment, only a plan for procedures, childbirth and injuries. Standard treatment controls inherited bleeding disorders rather than curing them, and most can be controlled well; gene therapy, described below, is an option for some adults with hemophilia B. For hemophilia, the core treatment replaces the missing clotting factor with an injection into a vein, using products made in a lab or purified from donated blood, which today carry a very low infection risk. People with severe hemophilia usually take it on a regular schedule to prevent bleeding (called prophylaxis), often injecting it themselves at home. People with milder forms may use it only when bleeding starts or before surgery. Some people develop inhibitors, antibodies that make replacement factor less effective, and then need a different approach. Emicizumab (Hemlibra), an antibody injected under the skin that stands in for factor VIII, is used to prevent bleeding in hemophilia A, with or without inhibitors. The US Food and Drug Administration has also approved a one-time gene therapy for some adults with hemophilia B; in its main study it raised factor IX levels and roughly halved the bleeding rate, but it suits only selected people and is a major decision to make with a specialist team. For many people with von Willebrand disease and for mild hemophilia A, desmopressin, a lab-made hormone, prompts the body to release its stored von Willebrand factor and factor VIII and can control minor bleeding. Tranexamic acid, a medicine that stops clots from breaking down too early, helps with dental work, nosebleeds and heavy periods, and hormonal birth control can reduce heavy menstrual bleeding. More serious cases use factor concentrates. For thrombophilias, a positive test alone usually does not mean daily treatment. After a clot, people take anticoagulants (blood thinners), such as warfarin, heparin injections, or a direct oral anticoagulant like apixaban (Eliquis) or rivaroxaban (Xarelto). Warfarin needs frequent blood tests to keep the dose right, while the direct oral anticoagulants do not. During pregnancy, warfarin and the direct oral anticoagulants are generally avoided because of risks to the baby, so heparin injections are used instead; anyone on a blood thinner who could become pregnant should plan this with their clinician before trying to conceive. The main trade-off with any blood thinner is a higher risk of bleeding, so how long to continue depends on what triggered the clot, whether it has happened before and which variant is present. People who have never had a clot may be given short-term preventive blood thinners at times of added risk, such as after surgery.

What to Expect

Outlook depends on the specific disorder and its severity. With modern treatment, people with hemophilia usually have a normal life expectancy, and with early diagnosis most people with von Willebrand disease lead normal, active lives. The main long-term problem in hemophilia is joint damage from repeated bleeding into joints, which regular prevention is designed to reduce. Treating a bleed early, often at home, shortens recovery and limits lasting harm, and physical therapy helps if damage has already occurred. Living with a bleeding disorder is mostly about planning rather than restriction. Regular exercise helps keep joints healthy, and a physical therapist can help choose suitable activities. Before any surgery or dental work, the surgeon or dentist needs to know about the condition, since extra treatment may be given beforehand. Aspirin and some other pain relievers increase bleeding, so it is worth checking new medicines with a pharmacist. Pregnancy and childbirth call for coordinated planning because of the risk of heavy bleeding after delivery, and this applies to hemophilia carriers too. Care is often organized through hemophilia treatment centers, which bring together hematologists, nurses, physical therapists and social workers. Many people carry a medical ID. With a thrombophilia, many people never have a clot. The practical work is limiting added risk: staying active, not smoking, getting up and moving on long trips, choosing birth control without estrogen (such as an intrauterine device, a progestin-only pill or implant, or a barrier method), and raising the diagnosis before surgery or pregnancy. People on long-term blood thinners have regular reviews to weigh clot protection against bleeding risk. Because these conditions run in families, a diagnosis often raises questions about relatives and future children. A genetic counselor can explain the chances of passing a variant on and the testing options.

When to Seek Help

See a clinician to be checked if you bruise easily, have frequent or long-lasting nosebleeds, bleed heavily after dental work, surgery or childbirth, have periods that last longer than 7 days or need a new pad or tampon every hour, or have a close relative with a bleeding disorder or unexplained clots. This is especially worth doing before planned surgery or pregnancy. If you have a bleeding disorder, treat a bleed as your plan directs and contact your treatment team right away for pain, swelling, tingling or stiffness in a joint or muscle, blood in the urine, or bleeding you cannot control with your usual treatment. If you have a thrombophilia, contact your care team right away about new swelling, pain, warmth or tenderness in one leg or arm, which can be a deep vein clot. Call 911 if someone with a bleeding disorder has a head injury or another serious injury, a sudden severe headache with confusion or vomiting, vomits or coughs up blood, or passes black or dark red stool. For someone with a thrombophilia, call 911 for sudden difficulty breathing, chest or upper back pain, a racing heartbeat or fainting, which can signal a clot in the lungs.

Questions to Ask Your Doctor

  1. 1.Which specific disorder do I have, and what do my test results say about how severe it is?
  2. 2.Do I need ongoing treatment, or only a plan for times of higher risk such as surgery, dental work or injury?
  3. 3.How should we plan for pregnancy, childbirth or birth control given this diagnosis?
  4. 4.Which of my relatives should be tested, and would genetic counseling help our family?
  5. 5.Which medicines, including over-the-counter pain relievers, should I avoid or check with you first?

Last reviewed • Oct 2026

Educational content, not medical advice.